DFTX Definium Therapeutics, Inc.: institutional ownership and insider trading
377 funds reported holding $5.64B of Definium Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $1.77B, with 147 new positions and 27 funds selling out; over the last 12 months insiders bought $0 and sold $7.00M on the open market.
Famous investors holding DFTX
- Stanley Druckenmiller (Duquesne Family Office): $16.8M, 0.3% of the portfolio
- Two Sigma (Two Sigma Investments): $43.4M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $106M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $17.7M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $14.8M, 0.0% of the portfolio
Largest institutional holders of DFTX
- BlackRock, Inc. (BLK) — $528M
- Avoro Capital Advisors LLC — $338M
- DRIEHAUS CAPITAL MANAGEMENT LLC — $322M
- Jupiter Topco LLC — $264M
- Capital World Investors — $252M
- FMR LLC — $224M
- PRICE T ROWE ASSOCIATES INC /MD/ — $219M
- GEODE CAPITAL MANAGEMENT, LLC — $171M
- STATE STREET CORP (STT, STT-PG) — $144M
- Capital International Investors — $139M
Recent DFTX insider trades
- Sep 25, 2026: Roberts Brandi sold 3,377 shares ($123K)
- Sep 25, 2026: Sullivan Mark sold 14,051 shares ($514K)
- Sep 25, 2026: Wiley Matthew T. sold 3,097 shares ($113K)
- Sep 25, 2026: Barrow Robert sold 31,550 shares ($1.15M)
5%+ owners
- DRIEHAUS CAPITAL MANAGEMENT LLC: 5.4% (Schedule 13G/A, filed Aug 14, 2026)